Emeritus ProfessorGlendaGillies

Professor in Neuroendocrine Pharmacology

With the support of a Wellcome Trust University Award, Glenda Gillies joined Charing Cross and Westminster Medical School as Senior Lecturer. Progressing to Reader and Professor at Imperial College, Faculty of Medicine, her career has incorporated a period as Wellcome Trust Research Leave Fellow. Her research interests relate to sex differences in structure and function in the brain, how these depend on the actions of sex and stress hormones during development and in adulthood, and how such differences contribute to sex differences in susceptibility to CNS disorders.

Initial work on the classical hypothalamic neuroendocrine system led to new discoveries on central factors controlling the stress response (two Nature papers), and sex-specific patterns of growth hormone release and growth rates. Associated work provided the first demonstration that very low levels of endocrine disrupting chemicals alter the developmental trajectory of hypothalamic dopaminergic neurones, highlighting the potential for environmental chemical pollutants to alter normal patterns of neuronal development.

Current work focuses on midbrain dopaminergic systems, disruptions to which are implicated in the commonest brain disorders, such as attention-deficit/hyperactivity-disorder, schizophrenia, drug abuse and Parkinson’s disease. These conditions affect men more than women, have putative developmental components, and are likely to benefit from sex-specific therapies, which currently are lacking. Recent findings include new insights into sex differences and steroid hormone influences within the nigrostriatal dopaminergic pathway (NSDA), highlighting sex dimorphisms under normal conditions and in experimental Parkinson’s disease. Collaborative work with Dr David Dexter and Professor Julia Buckingham has also demonstrated sex-specific effects of stress and glucocorticoid stress hormones in experimental PD, providing the first direct evidence for mechanisms by which stress may contribute to sex differences in neurodegenerative disease.

Recent scientific contributions include characterisation of sex differences in the 3D cytoarchitecture in adult midbrain dopaminergic neuronal populations of the ventral tegmental area, as well as the substantia nigra pars compacta, and discovery that this is disrupted by brief perinatal treatment with glucocorticoid stress hormones. This suggests novel mechanisms by which early environmental stressful challenges could impact on normal physiology, potentially leading to pathological change in later life in key brain pathways regulating adaptive behaviours. On-going work, in collaboration with Mark Ungless (Imperial) and Jeff Dalley (Cambridge) is investigating the functional consequences of this neurobiological programming at molecular, cellular and whole animal behavioural levels.

Recent collaborations: With Dr Egle Solito (William HarveyResearch Institute, QMUL) , we are characterising brain patterns of expression of the glucocorticid-inducible protein, Annexin-1, in the normal and injured (parkinsonian) rodent brain. This work suggests a role for Annexin-1 in regulating microglial effecrocytosis of degenerating dopamine-producing cells, and provides important evidence that annexin-1 is a key player in the resolution of inflammation in the brain, just as it is in the periphery.

Collaborators

• Professor ICAF Robinson, NIMR, Mill Hill
• Dr J. Dalley, Cambridge,
• Professor T. Robbins, Cambridge
• Dr M. Ungless, ICL
• Dr David Dexter, ICL
• Dr. Kevin O’Byrne, KCL
• Dr. E Solito, QMUL
• Professor Jolanta Opacka-Juffry, Roehampton

Teaching

I contribute to the undergraduate medicine MBBS courses and BMedSci/Graduate entry courses with lectures and tutorials in Pharmacology, Endocrinology and Neuroscience. As Course Director I take the academic lead for the Endocrinology BSc, and am also organiser of the module on ‘Neuroendocrinology, Health and Disease’ for this course

Recent key publications

• View all of my current publications
• McArthur, S. and Gillies, G. E.,” Peripheral vs. central sex steroid hormones in experimental Parkinson’s disease”.  Frontiers in Neuroendocrine Science  in press2011
• McArthur, S., Robinson, I.C.A.F. and Gillies, G. E., “Novel Ontogenetic Patterns of Sexual Differentiation in Arcuate Nucleus GHRH Neurons revealed in GHRH-Enhanced Green Fluorescent Protein Transgenic Mice” Endocrinology (2010), 152 (2): 607-617.
•  McArthur, S., Cristante, E., Paterno, M., Christian, H., Roncaroli, F., Gillies, G.E., Solito, E., “Annexin A1: a central player in the anti-inflammatory and neuro-protective roles of microglia” J. Immunology. 2010;. 185(10): 6317-28. 

• Gillies, G. E., McArthur S “Estrogen actions in the brain and the bases for differential actions in men and women: a case for sex-specific medicines”. Pharmacological Reviews  (2010), 62 (2): 155-198

• Gillies, G. E. McArthur, S. “Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson’s disease: a contribution to sex-specific neuroprotection by estrogens. Hormones and Behaviour (2010), 57(1): 23-34.
• Solito E.S., McArthur S., Christian H., Gavins, F., Buckingham, J.C., Gillies, G.E. “Annexin A1 in the brain – undiscovered roles?. Trends Pharmacol Sci (2008), 29(3): 135-142.
• McArthur, S., McHale E., Gillies G.E. “The size and distribution of midbraindopaminergic populations are permanently altered by perinatal glucocorticoid exposure in a sex- regionand time-specific manner”. Neuropsychopharmacology (2007), 32: 1462-1476.
• McArthur S, Murray, H.E. Dexter D. & Gillies G. “Striatal susceptibility to dopaminergic neurotoxins is independent of sex hormone effects on cell survival and DAT expression but exacerbated by central aromatase inhibition”. J.Neurochem. (2007), 100: 678-692.
• Warne, J.P., John, C. D., Christian H., C., Morris, J.F., Flower, R.J., Sugden D., Solito E., Gillies, G.E. & Buckingham, J.C. (2006). Gene deletion reveals roles for annexin 1 in the regulation of lipolysis and interleukin 6 release in visceral adipose tissue. Am J. Physiol. Endocrinol Metab. (2006) 291: E1264-1273.
• McArthur, S., Siddique, Z-L., Capone, G., Christian H.C., Theogaraj, C.D., John, C.D., Smith S.F., Morris, J.F., Buckingham, J.C., Gillies G.E. “Perinatal glucocorticoid treatment disrupts the hypothalamo-lactotroph axis in adult female but not male rats”. Endocrinology (2006), 147: 1904-15
• McArthur, S.R., McHale E., Dalley J., Buckingham, J.C. & Gillies, G.E. "Altered mesencephalic dopaminergic populations in adulthood as a consequence of brief perinatal glucocorticoid exposure". J. Neuroendocrinology (2005), 17 (8): 475-82.
• Gillies GE, Murray HE, Dexter D, McArthur S. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson’s disease”. Pharmacol Biochem Behav. (2004), 78: 513-22.
• Datla KP, Murray H.E., Pillai AV, Gillies GE and Dexter DT. “Differences in the susceptibilty of the nigrostriatal dopaminergic pathway to the neurotoxin 6-OHDA during the estrous cycle.” Neuroreport (2003), 14: 47-50.
• Murray, H.E., Pillai, A.V., McArthur, S.R., Razvi, N.,Datla,., K.P., Dexter, D.T. and Gillies, G.E. “Dose- and sex-dependent effects of the neurotoxin 6-OHDA on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females”. Neuroscience (2003), 116: 213-222.
• Pannell, C., Simonian, S. X., Gillies, G. E., Luscher, B., Herbison A. E. “ Hypothalamic somatostatin and growth hormone releasing hormone mRNA expression depend upon GABAA receptor expresion in the developing mouse. Neuroendocrinology (2002), 76: 93-98.
• Murray, H.E., Rantle, C.M., Simonian, S.X., Herbison, A.E. and Gillies, G.E. "Sexually dimorphic ontogeny of GABAergic influences on periventricular somatostatin neurons" Neuroendocrinology (1999), 70: 384-391.
• Christian, M. and Gillies, G. "Developing hypothalamic neurones as potential targets for environmental estrogens" J.Endocrinology 160, (1999), R1 – R6.
• Murray, H.E., Simonian, S.X., Herbison, A.E. and Gillies, G.E. "Ontogeny and sexual differentiation of somatostatin biosynthesis and secretion in the hypothalamic periventricular-median eminence pathway" J. Neuroendocrinology 11, (1999), 35-42
• Murray, H.E., Simonian, S.X., Herbison, A.E. and Gillies, G.E. "Correlation of hypothalamic somatostatin mRNA and peptide content with secretion: sexual dimorphism and differential regulation by gonadal factors" J. Neuroendocrinology 11, (1999), 27-33.